Impact
45 Sites
Mid-Study Deployment
From Frustration to Innovation: How an Intuitive, AI-Powered eCOA Revitalized a Phase IV Study
A top 20 global pharma client replaced a failing legacy eCOA vendor mid-trial
A leading global pharmaceutical company faced a critical challenge mid-study when their legacy eCOA platform failed to deliver. Patient enrollment had stalled, sites were frustrated, and the study timeline was at risk. By switching to an intuitive, AI-powered eCOA platform, they restored confidence, re-engaged sites, and unlocked novel clinical endpoints.
Key Results
- ✓ Restored site investigator confidence and resumed patient enrollment across all 45 sites
- ✓ Reduced dropout rates with an intuitive interface, automated reminders, and BYOD support
- ✓ Real-time data flow and AI video/voice analytics enabled novel AI-driven endpoints
Clinical trials depend on reliable data collection, and patient engagement is critical to success. When a legacy eCOA vendor fails to deliver an intuitive user experience, the consequences cascade: patients drop out, sites lose confidence, enrollment stalls, and the entire study is jeopardized. This global pharma company faced exactly this situation mid-study across 45 sites with hundreds of patients enrolled. The legacy platform was clunky, burdensome for patients, and lacked modern capabilities for real-time monitoring.
By deploying an AI-powered eCOA platform, the company completely transformed the patient and site experience. The new platform featured an intuitive mobile-first interface that patients actually wanted to use, automated reminder systems to boost compliance, and bring-your-own-device (BYOD) support to reduce barriers to entry. Behind the scenes, the platform leveraged AI to analyze video and voice data in real time, enabling investigators to track subtle behavioral and clinical markers between patient visits.
The impact was immediate and dramatic. Sites that had been frustrated with the legacy system re-engaged with the new platform. Patient enrollment resumed across all 45 sites, and dropout rates fell as patients found the new interface user-friendly and non-burdensome. Most importantly, the real-time data flow and AI video/voice analytics unlocked entirely novel endpoint possibilities that hadn't been feasible with the legacy system. The study not only recovered from near-failure but became a showcase for how modern technology can revolutionize clinical trial conduct.
Download the Case Study
Get the complete case study with all findings, data, and implementation details.
Want to see these results firsthand?
Let's talk about how Videra can help your organization achieve similar outcomes.